Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 678-684

  O'Driscoll, Gerard ^a   Green, Daniel ^b   Rankin, Jamie ^a   Stanton, Kim ^a   Taylor, Roger ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Angiotensin converting enzyme inhibition; Endothelium; Insulin dependent diabetes mellitus; Nitric oxide; Plethysmography

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; INSULIN; NITROPRUSSIDE SODIUM;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; ENDOTHELIUM CELL; HEART FAILURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAARTERIAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030840915     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119580     Document Type: Article

References (48)

1. Chowienczyk, P.J., G.F. Watts, J.R. Cockcroft, and J.M. Ritter. 1992. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1430-1432.
2. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator system appears impaired. J. Hypertens. 10:1025-1031.
3. Celermajer, D.S., K.E. Sorensen, D. Georgakopoulos, C. Bull, O. Thomas, J. Robinson, and J.E. Deanfield. 1993. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:2149-2155.
4. Celermajer, D.S., M.R. Adams, P. Clarkson, J. Robinson, R. McCredie, A. Donald, and J.E. Deanfield. 1996. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N. Engl. J. Med. 334: 150-154.
5. Reddy, K.G., R. Nair, H.M. Sheehan, and J.M. Hodgson. 1994. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23:833-843.
6. Celermajer, D.S., K.E. Sorensen, C. Bull, J. Robinson, and J.E. Deanfield. 1994. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24:1468-1474.
7. Tesfamariam, B., M.L. Brown, D. Deykin, and R.A. Cohen. 1990. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J. Clin. Invest. 85:929-932.
8. Bucala, R., K.J. Tracey, and A. Cerami. 1991. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87:432-438.
9. Calver, A., J. Collier, and P. Vallance. 1992. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90:2548-2554.
10. Elliott, T.G., J.R. Cockcroft, P.H. Groop, G.C. Viberti, and J.M. Ritter. 1993. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin. Sci. (Lond.). 85:687-693.
11. Johnstone, M.T., S.J. Creager, K.M. Scales, J.A. Cusco, B.K. Lee, and M.A. Creager. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:2510-2516.
12. Drexler, H., S. Kurz, M. Jeserich, T. Munzel, and B. Hornig. 1995. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am. J. Cardiol. 76:13E-18E.
13. Nakamura, M., T. Funakoshi, N. Arakawa, H. Yoshida, S. Makita, and K. Hiramori. 1994. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J. Am. Coll. Cardiol. 24:1321-1327.
14. Hirooka, Y., T. Imaizumi, H. Masaki, S. Ando, S. Harada, M. Momohara, and A. Takeshita. 1992. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 20:175-180.
15. Nakamura, M., T. Funakoshi, H. Yoshida, N. Arakawa, T. Suzuki, and K. Hiramori. 1992. Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J. Cardiovasc. Pharmacol. 20:949-954.
16. Mancini, G.B., G.C.H. Henry, C. Macaya, B.J. O'Neill, A.L. Pucillo, R.G. Carere, T.J. Wargovich, H. Mudra, T.F. Lüscher, M.I. Klibaner, et al. 1996. Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND Study (Trial on Reversing Endothelial Dysfunction). Circulation. 94: 258-265.
17. Bijlstra, P.J., P. Smits, J.A. Lutterman, and T. Thien. 1995. Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J. Cardiovasc. Pharmacol. 25: 658-664.
18. Viberti, G., C.E. Mogensen, L.C. Groop, and J.F. Pauls. 1994. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. J. Am. Med. Assoc. 271:275-279.
19. Laffel, L.M.B., J.B. McGill, and D.J. Gans. 1995. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am. J. Med. 99: 497-504.
20. Green, D.J., D.T. Fowler, J.G. O'Driscoll, B.A. Blanksby, and R. Taylor. 1996. Endothelium-derived nitric oxide activity in forearm vessels of tennis players. J. Appl. Physiol. 81:943-948.
21. Benjamin, N., A. Calver, J. Collier, B. Robinson, P. Vallance, and D. Webb. 1995. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25:918-913.
22. Green, D.J., J.G. O'Driscoll, B.A. Blanksby, and R.R. Taylor. 1995. Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. Clin. Sci. 89:343-348.
23. Antony, I., G. Lerebours, and A. Nitenberg. 1996. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation. 94:3115-3122.
24. Celermajer, D.S., K.E. Sorensen, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J.E. Deanfield. 1994. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24:471-476.
25. Smits, P., J.A. Kapma, M.C. Jacobs, J. Lutterman, and T. Thien. 1993. Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes. 42:148-153.
26. Halkin, A., N. Benjamin, H.S. Doktor, S.D. Todd, G. Viberti, and J.M. Ritter. 1991. Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin. Sci. (Lond.). 81:223-232.
27. McVeigh, G.E., G.M. Brennan, G.D. Johnston, B.J. McDermott, L.T. McGrath, W.R. Henry, J.W. Andrews, and J.R. Hayes. 1992. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:771-776.
28. Williams, S.B., J.A. Cusco, M.A. Roddy, M.T. Johnstone, and M.A. Creager. 1996. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27:567-574.
29. Nitenberg, A., P. Valensi, R. Sachs, M. Dali, E. Aptecar, and J.R. Attali. 1993. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1017-1025.
30. Brownlee, M., A. Cerami, and H. Vlassara. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321.
31. Kawamura, M., J.W. Heinecke, and A. Chait. 1994. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest. 94:771-778.
32. Baynes, J.W. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405-412.
33. Ting, H.H., F.K. Timimi, K.S. Boles, S.J. Creager, P. Ganz, and M.A. Creager. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:22-28.
34. Rajagopalan, S., and D.G. Harrison. 1996. Reversing endothelial dysfunction with ACE inhibitors. A new TREND? Circulation. 94:240-243.
35. Scherrer, U., D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94:2511-2515.
36. Torlone, E., M. Britta, A.M. Rambotti, G. Perriello, F. Santeusanio, P. Brunetti, and G.B. Bolli. 1993. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care. 16:1347-1355.
37. Taddei, S., A. Viridis, P. Mattei, A. Natali, E. Ferrannini, and A. Salvetti. 1995. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 92:2911-2918.
38. Petrie, J.R., S. Ueda, D.J. Webb, H.L. Elliott, and J.M.C. Connell. 1996. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 93: 1331-1333.
39. Rajagopalan, S., S. Kurz, T. Münzel, M. Tarpey, B. Freeman, K. Griendling, and D. Harrison. 1996. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1916-1923.
40. Andreoli, S.P. 1993. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. Am. J. Physiol. 264: F120-F127.
41. Haklar, G., C. Ersahin, H. Moini, M. Sungun, N. Dogan, S. Bilsel, K. Emerk, and A.S. Yalcin. 1995. Protective effects of cilazapril against free radical injury in myocardial ischaemia-reperfusion. Pharmacol. Res. 31:33-36.
42. Kaufman, M.J. 1994. Comparison of the free radical-scavenging ability of captopril and ascorbic acid in an in-vitro model of lipid oxidation. Implications for reperfusion injury and ACE inhibitor therapy. J. Pharm. Pharmacol. 46:217-220.
43. Mira, M.L., M.M. Silva, M.J. Queiroz, and C.F. Manso. 1993 Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic. Res. Commun. 19:173-181.
44. Vanhoutte, P.M., C.M. Boulanger, and J.V. Mombouli. 1995. Endothelium-derived relaxing factors and converting-enzyme inhibition. Am. J. Cardiol. 76:3E-12E.
45. Auch-Schwelk, W., E. Duske, M. Claus, K. Graf, M. Gräfe, and E. Fleck. 1995. Endothelium-mediated vasodilation during ACE inhibition. Eur. Heart J. 16(Suppl. C):59-65.
46. Clapperton, M., J. McMurray, A.C. Fisher, and H.J. Dargie. 1994. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro. Br. J. Clin. Pharmacol. 38:53-56.
47. Fennessy, P.A., J.H. Campbell, and G.R. Campbell. 1994. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. Atherosclerosis. 106: 29-41.
48. Farhy, R.D., K.L. Ho, O.A. Carretero, and A.G. Scicli. 1992. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem. Biophys. Res. Commun. 182:283-288.